Cargando…

Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies

OBJECTIVE: To increase equitable access to life insurance for HIV-positive individuals by identifying subgroups with lower relative mortality. DESIGN: Collaborative analysis of cohort studies. METHODS: We estimated relative mortality from 6 months after starting antiretroviral therapy (ART), compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaulich-Bartz, Josee, Dam, Wayne, May, Margaret T., Lederberger, Bruno, Widmer, Urs, Phillips, Andrew N., Grabar, Sophie, Mocroft, Amanda, Vilaro, Josep, van Sighem, Ard, Moreno, Santiago, Dabis, François, Monforte, Antonella D’Arminio, Teira, Ramon, Ingle, Suzanne M., Sterne, Jonathan A.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2013
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678894/ https://www.ncbi.nlm.nih.gov/pubmed/23449349 http://dx.doi.org/10.1097/QAD.0b013e3283601199

Ejemplares similares

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients
por: Ingle, Suzanne M., et al.
Publicado: (2014)

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
por: Helleberg, Marie, et al.
Publicado: (2015)

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings
por: Trickey, Adam, et al.
Publicado: (2019)

sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
por: Loosli, Tom, et al.
Publicado: (2023)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies
por: Trickey, Adam, et al.
Publicado: (2020)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Role of In Vitro Stimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients
por: Tincati, Camilla, et al.
Publicado: (2012)

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
por: Trickey, Adam, et al.
Publicado: (2016)

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
por: Sabin, Caroline A., et al.
Publicado: (2016)

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
por: Mocroft, A, et al.
Publicado: (2014)

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2011)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
por: Kovari, Helen, et al.
Publicado: (2016)

A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study
por: Sönnerborg, A, et al.
Publicado: (2010)

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis
por: Willemse, Sophie, et al.
Publicado: (2019)

Caring for women living with HIV: gaps in the evidence
por: Loutfy, Mona R, et al.
Publicado: (2013)

HIV-Infected Late Presenter Patients
por: D'Arminio Monforte, Antonella, et al.
Publicado: (2012)

Illness Representations of HIV Positive Patients Are Associated with Virologic Success
por: Leone, Daniela, et al.
Publicado: (2016)

Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy
por: Lodwick, Rebecca K., et al.
Publicado: (2015)

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023)

Management of Chronic Hepatitis B in HIV-Coinfected Patients
por: Fasano, Massimo, et al.
Publicado: (2022)

Efficient immune reconstitution in HIV+ naïve patients (pts) starting a first lopinavir/ritonavir-containing regimen with low CD4 counts
por: Merlini, E, et al.
Publicado: (2010)

Invariant Natural Killer T (iNKT) Cells in HAART-Treated, HIV-Positive Patients with Bone and Cardiovascular Impairment
por: Tincati, Camilla, et al.
Publicado: (2014)

Moving towards zero new HIV infections: The importance of combination prevention
por: van Sighem, Ard, et al.
Publicado: (2022)

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis
por: Girardi, Enrico, et al.
Publicado: (2012)

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection
por: Lodi, Sara, et al.
Publicado: (2022)

Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA
por: Iannuzzi, Francesca, et al.
Publicado: (2014)

HIV-Indicator Condition Guided Testing in a Hospital Setting
por: Barbanotti, Diletta, et al.
Publicado: (2023)

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients
por: Saracino, Annalisa, et al.
Publicado: (2018)

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy
por: Saracino, Annalisa, et al.
Publicado: (2018)

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016)

Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)
por: Sullivan, Ann K., et al.
Publicado: (2013)

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?
por: Shanyinde, Milensu, et al.
Publicado: (2019)

Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological Disorders
por: Giancola, Maria Letizia, et al.
Publicado: (2012)

Reduced HIV symptoms and improved health-related quality of life correlate with better access to care for HIV-1 infected women: the ELLA study
por: Baran, Robert, et al.
Publicado: (2014)

Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection
por: Bai, Francesca, et al.
Publicado: (2012)

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort
por: Saracino, Annalisa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nv9t22psneom0q7qs1e25u3dif